HFA Premium Access

Know it by heart – New opportunities for cardiologists in the Sodium-Glucose-Co-Transporter 2 (SGLT2) inhibitor era

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure
Topic: Diabetes and the Heart
Session type: Satellite Symposium
Sponsored by Boehringer Ingelheim & Eli Lilly and Company Alliance
Date: 27 May 2019
Time: 12:45 - 13:45

Congress Session

5 presentations in this session

Welcome and introduction - Know it by heart – New opportunities for cardiologists in the SGLT2 inhibitor era.

Speaker: Professor F. Ruschitzka (Zurich, CH)
Thumbnail

SGLT2 inhibitors: what is the evidence so far?

Speaker: Professor J. Butler (Jackson, US)
Thumbnail

Advancing evidence-based care in patients with type 2 diabetes: new opportunities for cardiologists.

Speaker: Professor R. Fontes Carvalho (Vila Nova de Gaia, PT)
Thumbnail

Ongoing studies with SGLT2 inhibitors: how may new and emerging evidence inform future clinical practice?

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Thumbnail

Summary and close - Know it by heart – New opportunities for cardiologists in the SGLT2 inhibitor era.

Speaker: Professor F. Ruschitzka (Zurich, CH)
Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Thumbnail

6 speakers from this session

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
82 presentations
4 followers

Professor Javed Butler

The University of Mississippi Medical Center, Jackson (United States of America)
71 presentations
5 followers

Professor Ricardo Fontes Carvalho

Hospital Center of Vila Nova de Gaia/Espinho, Vila Nova de Gaia (Portugal)
20 presentations
0 follower

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
70 presentations
1 follower

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
82 presentations
4 followers

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
70 presentations
1 follower

This platform is supported by

logo Novo Nordisk